Laca, Ibrahim A.
HRN: 28-11-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2026
CEFTRIAXONE 1G (VIAL)
01/04/2026
01/10/2026
IV
2g
OD
Fistula-in-Ano
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes